Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Nexgel (NXGL) EBT (2018 - 2025)

Historic EBT for Nexgel (NXGL) over the last 8 years, with Q3 2025 value amounting to -$647000.0.

  • Nexgel's EBT rose 1419.1% to -$647000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.8 million, marking a year-over-year increase of 2708.5%. This contributed to the annual value of -$3.5 million for FY2024, which is 862.61% down from last year.
  • Per Nexgel's latest filing, its EBT stood at -$647000.0 for Q3 2025, which was up 1419.1% from -$640000.0 recorded in Q2 2025.
  • Nexgel's EBT's 5-year high stood at -$552000.0 during Q3 2023, with a 5-year trough of -$1.8 million in Q1 2022.
  • Over the past 5 years, Nexgel's median EBT value was -$825000.0 (recorded in 2021), while the average stood at -$904000.0.
  • Its EBT has fluctuated over the past 5 years, first tumbled by 16079.55% in 2022, then surged by 5604.58% in 2023.
  • Over the past 5 years, Nexgel's EBT (Quarter) stood at -$887000.0 in 2021, then tumbled by 38.33% to -$1.2 million in 2022, then grew by 3.26% to -$1.2 million in 2023, then surged by 30.58% to -$824000.0 in 2024, then rose by 21.48% to -$647000.0 in 2025.
  • Its EBT stands at -$647000.0 for Q3 2025, versus -$640000.0 for Q2 2025 and -$678000.0 for Q1 2025.